Med Ed Report briefs: May 2013

Share this article:
Erin Nagle
Erin Nagle

Pfizer's Medical Education Group (MEG) adopted a new name, Independent Grants for Learning & Change (IGLC), to better align with its 2012 shift toward quality and performance improvement.

Novartis and Teva lent support for a CME/CE initiative in multiple sclerosis. The personalized, teleconference-based activity—produced by Med-IQ—is designed to help NPs and PAs identify patients who are appropriate for disease-modifying therapy.

StemScientific, a division of KnowledgePoint360 Group, named Erin Nagle VP, medical & scientific services. She will lead teams of scientific directors and medical writers.

Roche said it will release to researchers the full clinical study reports on all 74 trials it sponsored for influenza drug Tamiflu. Cochrane Collaboration reviewers, which requested the data more than three years ago, said Roche has previously promised access to oseltamivir data.

The 4th annual PharmedOut conference is scheduled for June 6-7 at Georgetown University. “Medical Behavior in a Commercial World: Who is Responsible?” will feature speakers including Marcia Angell and Daniel Carlat.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions